How the NLRP3 inflammation 'switch' turns on
Elucidating the functional mechanism of NLRP3 inflammasome activation
Researchers are figuring out how the NLRP3 inflammation switch turns on, which could help people with Alzheimer's, gout, and other inflammation-linked diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11335720 on NIH RePORTER |
What this research studies
From a patient's point of view, scientists are examining the molecular parts of the NLRP3 protein to see how it senses danger signals such as amyloid-β, extracellular ATP, and crystals. They will use lab-grown cells, biochemical tests, and structural approaches to watch how the central ATPase (NACHT) domain and other pieces change when NLRP3 activates. The team will test how specific mutations or signals trigger the chain of events that lead to inflammatory cytokine release and cell death. Mapping these steps aims to reveal specific targets that could be blocked to prevent harmful inflammation.
Who could benefit from this research
Good fit: People with Alzheimer’s disease, gout, or other inflammatory conditions tied to NLRP3 signaling might be eligible for future related studies or to donate samples to this line of research.
Not a fit: Patients whose conditions are unrelated to inflammatory or NLRP3-driven biology are unlikely to gain direct benefit from this work.
Why it matters
Potential benefit: If successful, this work could point to new ways to stop harmful inflammation in Alzheimer’s, gout, cardiovascular disease, and other conditions driven by NLRP3.
How similar studies have performed: Previous laboratory and animal studies targeting NLRP3 have reduced inflammation and disease signs, but translating those findings into safe, effective human therapies remains an early-stage challenge.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wu, Hao — Boston Children's Hospital
- Study coordinator: Wu, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.